Boston Trust Walden Corp CHE — CHEMED CORP

Ownership history in Boston Trust Walden Corp  ·  43 quarters on record

AI Ownership Summary

Boston Trust Walden Corp reported CHEMED CORP (CHE) in 43 quarterly 13F filings from 2023 Q4 through 2026 Q1. Peak portfolio weight reached 1.11% in 2025 Q1. The latest visible filing shows CHE at 0.64% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this CHE ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Boston Trust Walden Corp's position in CHEMED CORP, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q1

CHE was reported at 0.64% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
1.11% in 2025 Q1

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2023 Q4 to 2026 Q1

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

CHE stock page Boston Trust Walden Corp fund profile Boston Trust Walden Corp full holdings
How Boston Trust Walden Corp held CHE — position size vs. price
% of Fund (quarterly)    CHE price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 10 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q1 REDUCED — — — 205,197 -16,044 -7.3% 0.64% $77.5M 2026-04-24 $421.11
2025 Q4 REDUCED 5.6% -11.6% ✅ 221,241 -13,225 -5.6% 0.71% $94.7M 2026-01-28 $432.01
2025 Q3 REDUCED 5.2% -2.8% ✅ 234,466 -12,968 -5.2% 0.77% $105.0M 2025-10-17 $439.40
2025 Q2 ADDED — — — 247,434 +1,083 +0.4% 0.86% $120.5M 2025-07-28 $464.21
2025 Q1 ADDED — — — 246,351 +4,179 +1.7% 1.11% $151.6M 2025-04-21 $560.87
2024 Q4 ADDED — — — 242,172 +22,105 +10.0% 0.90% $128.3M 2025-01-24 $547.78
2024 Q3 REDUCED — — — 220,067 -1,373 -0.6% 0.92% $132.3M 2024-10-24 $592.86
2024 Q2 ADDED — — — 221,440 +11,036 +5.2% 0.89% $120.1M 2024-07-19 $538.91
2024 Q1 ADDED — — — 210,404 +11,257 +5.7% 0.96% $135.1M 2024-04-22 $599.42
2023 Q4 REDUCED 7.9% +9.6% ❌ 199,147 -17,190 -7.9% 0.88% $116.5M 2024-01-24 $587.24
33 older quarters hidden  —  Sign in free or upgrade to Premium to see full history

🏢 Other funds also holding CHE

As of 2026 Q1 — sorted by position size

Strong Retirement Solutions LLC 1.99% Laurus Global Equity Management Inc. 3Y 1.27% Formidable Asset Management, LLC 3Y 7Y 0.94% Abacus FCF Advisors LLC 3Y 7Y 0.69% Lord & Richards Wealth Management, LLC 0.59% Signal Advisors Wealth, LLC 0.48% RIVERBRIDGE PARTNERS LLC 3Y 7Y 0.47% Park Place Capital Corp 3Y 0.34% MITCHELL & PAHL PRIVATE WEALTH, LLC 3Y 0.24% Legacy Wealth Asset Management, LLC 3Y 0.22%

FAQ About Boston Trust Walden Corp and CHE

These are the practical questions this page is built to answer before you even open the full history table.

How long has Boston Trust Walden Corp reported owning CHE?

Boston Trust Walden Corp reported CHE across 10 quarterly 13F filings, from 2023 Q4 through 2026 Q1.

What was the largest reported CHE position in Boston Trust Walden Corp's portfolio?

The largest reported portfolio weight for CHE was 1.11% in 2025 Q1.

What is the latest reported CHE position on this page?

The most recent filing on this page is 2026 Q1, when Boston Trust Walden Corp reported 205,197 shares, equal to 0.64% of portfolio, with an estimated market value of $77.5M.

What does the chart on this CHE ownership page compare?

The chart compares Boston Trust Walden Corp's quarterly CHE portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did Boston Trust Walden Corp time their CHE position?

Based on 13F filing dates vs. subsequent CHE price moves, Boston Trust Walden Corp correctly timed 21 out of 42 reported position changes (50%).

← Back to Boston Trust Walden Corp Holdings